This cluster of papers focuses on the development and evaluation of protein phosphatase inhibitors, such as Cantharidin and Norcantharidin, as potential anticancer agents. The research involves studying their mechanisms of action, including induction of apoptosis, cell cycle arrest, and inhibition of cancer cell growth. Additionally, the cluster explores the molecular identification of pederin biosynthesis and the pharmacological evaluation of these inhibitors.